USPTO 2015–2025 USPTO PatentsView US Corporation

Depuy Synthes Products, Inc.

USPTO PatentsView assignee record - 2,257 granted patents across 127 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

2,257

Total patents granted

127

CPC technology areas

17.1

Avg claims per patent

-17%

5-year filing velocity

The verdict

Depuy holds 2,257 US patents across 127 technology areas, rank #174 of 50,000 tracked assignees.

#174
of 50,000 US assignees by volume: Top 1%
by Innovation Score (67.0/100): 17.1
avg claims per patent: -17%
filing velocity, last 5 yrs

Portfolio overview

Depuy Synthes Products, Inc. has been granted 2,257 US utility patents between 2015 and 2025, placing Depuy Synthes Products, Inc. at rank #174 across all assignees tracked by PlainPatent. This portfolio spans 127 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.1 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Depuy Synthes Products, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Depuy sits between NTT Docomo, Inc. (2,283 patents, rank #170) and Visa International Service Association (2,222 patents, rank #178) - the closest US assignees by grant volume. The composite Innovation Score of 67.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1,025 grants, compared with 1,232 in the 2015–2019 window, a -17% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Depuy Synthes Products, Inc.'s 17.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Depuy Synthes Products, Inc. against peers pursuing similar technology classes.

NTT Docomo

2,283
Hyundai Mobis

2,279
The Board of Trus…

2,275
LG Energy Solution

2,270
Depuy Synthes Pro… ◀

2,257
Becton Dickinson…

2,235
Sumitomo Rubber I…

2,232
Daikin Industries

2,229
Visa Internationa…

2,222

What this shows Depuy holds 2,257 patents at rank #174, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Depuy

By rank, the assignees closest to #174 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Depuy's primary technology class.

Depuy's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

67 Top 1% higher than 99% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Depuy Synthes Products, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	272	12.1%
2016	249	11.0%
2017	267	11.8%
2018	214	9.5%
2019	230	10.2%
2020	227	10.1%
2021	203	9.0%
2022	175	7.8%
2023	166	7.4%
2024	166	7.4%
2025	88	3.9%

Which technologies does Depuy Synthes Products, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1,796

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 851

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 161

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 135

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 90

H04N - PICTORIAL COMMUNICATION, e.g. TELEVISION 79

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 68

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 67

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 46

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 41

B25B - TOOLS OR BENCH DEVICES NOT OTHERWISE PROVIDED FOR, FOR FASTENING, CONNECTING, DISENGAGING OR HOLDING 34

B33Y - ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING 31

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 31

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 29

Y10S - TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS 25

Top 15 of 127 technology areas

Patent Moat Analysis

Portfolio Volume Strong

Tech Breadth Diversified

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#174

Across all tracked assignees

Innovation Score

67.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Depuy Synthes Products, Inc. hold?

Depuy Synthes Products, Inc. holds 2,257 US granted patents filed between 2015 and 2025, spanning 127 technology areas.

What is Depuy Synthes Products, Inc.'s Innovation Score?

Depuy Synthes Products, Inc. has an Innovation Score of 67.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Depuy Synthes Products, Inc. focus on?

Depuy Synthes Products, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 1,796 patents. The company has filed patents in 127 CPC subclasses total.

Is Depuy Synthes Products, Inc.'s patent filing rate increasing or decreasing?

Depuy Synthes Products, Inc.'s recent filing velocity is -17% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Depuy Synthes Products, Inc.'s patents?

Depuy Synthes Products, Inc.'s patents average 17.1 claims each. This falls within the standard range, providing solid legal coverage.

How is the Depuy Synthes Products, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Depuy's 2,257 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Depuy ranks #174 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.